BUSINESS

Corporate actions: asset sale, CEO changes, earnings, conferences

▪

Read, Watch or Listen

Media Bias Meter

Sources: 8

Center 100%

Sources: 8

United States. Between March 9 and March 10, 2026, multiple publicly traded companies issued investor communications disclosing corporate actions. Alexander's announced a definitive agreement to sell its Rego Park I property to Northwell Health for $235.5 million gross, producing $202 million net proceeds. West Pharmaceutical's CEO Eric M. Green notified the board of his planned retirement pending successor hiring. Mesa Laboratories named Siddhartha Kadia as incoming CEO effective April 13, 2026. Velo3D scheduled fiscal 2025 results for March 24, 2026. ESS and ASP Isotopes confirmed participation in investor conferences and webcast presentations. Based on 7 articles reviewed and supporting research.

Prepared by Christopher Adams and reviewed by editorial team.

Timeline of Events

March 9, 2026 — Alexander's announced sale agreement for Rego Park I to Northwell Health.
March 9, 2026 — West Pharmaceutical's CEO Eric M. Green informed board of planned retirement.
March 9, 2026 — Mesa Laboratories announced CEO change; Siddhartha Kadia to assume role April 13, 2026.
March 9, 2026 — Velo3D scheduled its fiscal 2025 results release and earnings call for March 24, 2026.
March 10, 2026 — ESS and ASP Isotopes confirmed attendance and presentations at investor conferences (ROTH; Canaccord Genuity).

Why This Matters to You

These corporate actions can impact your investments. If you own shares in Alexander's, West Pharmaceutical, Mesa Laboratories, Velo3D, ESS, or ASP Isotopes, keep an eye on market reactions. Check your portfolio and consider how these changes might affect your financial strategy.

The Bottom Line

Big moves are happening in the corporate world. From property sales to CEO changes, these actions can shake up stock prices. Stay informed about your investments. Worth forwarding if you know someone with stocks in these companies.